General ENT News

ENT

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ghannoum G et al. - The study indicates that recent clinical isolates remain susceptible to this antifungal and that MICON could be used as first-line treatment for oropharyngeal candidiasis.